Skip to main content
Clinical Trials/NCT02579161
NCT02579161
Completed
Phase 3

Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy

Northwell Health2 sites in 1 country98 target enrollmentSeptember 2014

Overview

Phase
Phase 3
Intervention
cephalosporins
Conditions
Kidney Stones
Sponsor
Northwell Health
Enrollment
98
Locations
2
Primary Endpoint
Number of Participants With Infectious Complications
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The Investigators objective is to compare the clinical efficacy of a single-day protocol with a short-course protocol for PCNL. The investigator hope is to reduce the use of possibly unnecessary prolonged antibiotic use, reduce hospital costs and prevent the further propagation of resistant microbes.

Detailed Description

For large renal stone burdens and/or complex stones, Percutaneous Nephrolithotomy (PCNL) has become the mainstay for treatment, replacing open kidney stone surgery since it's introduction in 1976. However, PCNL is not without its complications, specifically infectious. The procedure carries up to 25% incidence of infectious complications with approximately 1% rate of severe sepsis even with completely sterile conditions. Therefore, the use of antibiotics becomes paramount, but to date there are no PNCL specific guidelines for the appropriate duration and class of antibiotics. This fact leaves the practicing urologists to their own subjective experiences to the guide them. In addition, in an age where there are increasing numbers of resistant microbes the judicious use of antibiotics is in even more paramount. The investigators of this project, purpose a randomized intention to treat prospective study to explore the duration and type of antibiotics in a larger population then previously studied. The investigators hypothesize that there will be no difference in complications between two groups: 1) 24 hours of perioperative antibiotics versus 2) Continued antibiotics until the removal of any external catheters. The investigators will model the antibiotics choices and duration after the 2013 American Urological Association, (AUA) Urologic Surgery Antimicrobial Prophylaxis recommendations, modified by our local antibiogram as necessary. The investigators' objective is to compare the clinical efficacy of a single-day protocol with a short-course protocol for PCNL. Our hope is to reduce the use of possibly unnecessary prolonged antibiotic use, reduce hospital costs and prevent the further propagation of resistant microbes. Antibiotic detail: cephalosporins or aminoglycoside + metronidazole or clindamycin and the alternative for allergies being aminoglycoside/ sulbactam or fluoroquinolone Looking at the same drugs and doses the variable is the timeframe of the medication

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
December 2018
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients \>18 years old
  • Negative urine culture within 1 month prior to procedure
  • Renal Calculi which would optimally require PCNL for treatment.

Exclusion Criteria

  • Patients \<18 years old.
  • Patients who are not able to give consent for study
  • Patients currently on antibiotics immediately prior to the procedure
  • Previous history of sepsis or SIRS from stone manipulations
  • Foley catheter in place for greater than 1 week duration
  • Patients under going planned, multi-staged procedures
  • Immunosuppressed patients

Arms & Interventions

Antibiotics for a 24 hour period

Antibiotics for a 24 hour period Intervention drug to be determined based on patient history etc.

Intervention: cephalosporins

Antibiotics for a 24 hour period

Antibiotics for a 24 hour period Intervention drug to be determined based on patient history etc.

Intervention: Fluoroquinolones

Antibiotics for a 24 hour period

Antibiotics for a 24 hour period Intervention drug to be determined based on patient history etc.

Intervention: Clindamycin

Antibiotics for a 24 hour period

Antibiotics for a 24 hour period Intervention drug to be determined based on patient history etc.

Intervention: Ampicillin/Gentamicin

Continued antibiotics

Continued antibiotics until the removal of any external catheters Intervention drug to be determined based on patient history etc.

Intervention: cephalosporins

Continued antibiotics

Continued antibiotics until the removal of any external catheters Intervention drug to be determined based on patient history etc.

Intervention: Fluoroquinolones

Continued antibiotics

Continued antibiotics until the removal of any external catheters Intervention drug to be determined based on patient history etc.

Intervention: Clindamycin

Continued antibiotics

Continued antibiotics until the removal of any external catheters Intervention drug to be determined based on patient history etc.

Intervention: Ampicillin/Gentamicin

Outcomes

Primary Outcomes

Number of Participants With Infectious Complications

Time Frame: 0-30 days post-operatively

Compare the rate of infectious complications following a single-dose of peri-operative protocol (antibiotics for 24 hours as recommended by the American Urological Association Guidelines) with a short-course protocol (antibiotics continued until any external catheters such as nephrostomy tubes are removed) following percutaneous nephrolithotomy. Complication rate differences, primarily infectious complications such as fever, sepsis, systemic inflammatory response.

Secondary Outcomes

  • Length of Stay (Days)(0-30 days post operatively)
  • Number of Participants With Associated Clavien Grade of Adverse Event(0 to 30 days after surgery)

Study Sites (2)

Loading locations...

Similar Trials